Developability assessment: Why, What, and How - Webinar by BioIntron
Developability is an increasingly critical concept in antibody discovery and development.
Previously associated with late-stage outcomes such as stability and formulation, developability assessment is now integrated earlier in the discovery process to enable multidimensional profiling of lead candidates.
- How developability guides real-world projects. From optimizing machine learning algorithms with AI to enabling stability-driven antibody engineering, developability insights are becoming deeply embedded in discovery workflows. As our understanding evolves, so too will its role in shaping the future of drug development.
- Why developability assessments are essential at multiple stages. As biologics grow more complex, early evaluation is key to identifying promising leads. Evidence shows clear correlations between developability parameters and pharmacokinetic (PK) behavior.
- What developability entails. It refers to key biophysical properties such as hydrophobicity, thermal stability, colloidal stability, non-specific binding, and surface charge that collectively inform candidate viability. Our comprehensive assessments complement functional data to support lead selection.
Start Time:
October 23, 2025 11:00 AM Eastern
12:00 PM Atlantic, 10:00 AM Central, 9:00 AM Mountain, 8:00 AM Pacific
Add to Calendar:
Estimated Length:
1 hour
Registration Time Remaining:
48 days